Home/Filings/4/0001567619-19-018455
4//SEC Filing

Templeman Blaine 4

Accession 0001567619-19-018455

CIK 0001435049other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 6:32 PM ET

Size

14.6 KB

Accession

0001567619-19-018455

Insider Transaction Report

Form 4
Period: 2019-09-13
Templeman Blaine
Executive VP, General Counsel
Transactions
  • Sale

    Common Stock

    2019-09-13$1.31/sh6,990$9,128122,888 total
  • Sale

    Common Stock

    2019-09-13$1.31/sh5,888$7,689117,000 total
Footnotes (2)
  • [F1]The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.3450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001653641

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 6:32 PM ET
Size
14.6 KB